Ticker
TRDACompany Name
ENTRADA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Gross Profit | Gross Margin | Revenues |
---|---|---|---|
6/30/2025 | $ 79.48M | 100% | $ 79.48M |
3/31/2025 | $ 172.22M | 100% | $ 172.22M |
12/31/2024 | $ 210.78M | 100% | $ 210.78M |
9/30/2024 | $ 215.23M | 100% | $ 215.23M |
6/30/2024 | $ 239.4M | 100% | $ 239.4M |
3/31/2024 | $ 162.87M | 100% | $ 162.87M |
12/31/2023 | $ 129.01M | 100% | $ 129.01M |
9/30/2023 | $ 87.17M | 100% | $ 87.17M |
6/30/2023 | $ 43.43M | 100% | $ 43.43M |
3/31/2023 | $ 25.26M | 100% | $ 25.26M |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
GP / Revenues
(=) Gross %
Gross % for ENTRADA THERAPEUTICS INC is calculated as follows: GP [ $ 0 ] / Revenues [ $ 0 ]
(=) Gross % [ 0% ]
Minimum
Mar 31, 2023
Maximum
Mar 31, 2023
Average
Median
filtered constituents | 3.81K |
---|---|
min | -72.25% |
max | 150.26% |
average | 53.09% |
median | 49.46% |
std | 31.59% |